Cargando…
Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170397/ https://www.ncbi.nlm.nih.gov/pubmed/34093394 http://dx.doi.org/10.3389/fneur.2021.645913 |
_version_ | 1783702234557579264 |
---|---|
author | Dominguez, Jacqueline Yu, Jeryl Tan Tan, Yi Jayne Ng, Arlene De Guzman, Ma Fe Natividad, Boots Daroy, Ma Luisa Cano, Jemellee Yu, Justine Lian, Michelle M. Zeng, Li Lim, Weng Khong Foo, Jia Nee Ng, Adeline S. L. |
author_facet | Dominguez, Jacqueline Yu, Jeryl Tan Tan, Yi Jayne Ng, Arlene De Guzman, Ma Fe Natividad, Boots Daroy, Ma Luisa Cano, Jemellee Yu, Justine Lian, Michelle M. Zeng, Li Lim, Weng Khong Foo, Jia Nee Ng, Adeline S. L. |
author_sort | Dominguez, Jacqueline |
collection | PubMed |
description | Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis, particularly in cases with both FTD and amyotrophic lateral sclerosis (FTD-ALS). Mutations in three genes are associated with the majority of familial FTD (fFTD) cases - microtubule associated protein tau gene (MAPT), granulin precursor (GRN), and hexanucleotide repeat expansions in chromosome 9 open reading frame 72- SMCR8complex subunit (C9orf72) while mutations in other genes such as optineurin (OPTN) have rarely been reported. Mutations in OPTN have been reported mostly in familial and sporadic cases of ALS, or in rare cases of FTD-ALS, but not in association with pure or predominant FTD and/or parkinsonian phenotype. Here, we report for the first time, a family from the Philippines with four members harboring a novel frameshift insertion at OPTN (Chr 10:13166090 G>GA) p.Lys328GluTer11, three of whom presented with FTD-related phenotypes. Additionally, one sibling heterozygous for the frameshift insertion had a predominantly parkinsonian phenotype resembling corticobasal syndrome, but it remains to be determined if this phenotype is related to the frameshift insertion. Notably, none of the affected members showed any evidence of motor neuron disease or ALS at the time of writing, both clinically and on electrophysiological testing, expanding the phenotypic spectrum of OPTN mutations. Close follow-up of mutation carriers for the development of new clinical features and wider investigation of additional family members with further genetic analyses will be conducted to investigate the possibility of other genetic modifiers in this family which could explain phenotypic heterogeneity. |
format | Online Article Text |
id | pubmed-8170397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81703972021-06-03 Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis Dominguez, Jacqueline Yu, Jeryl Tan Tan, Yi Jayne Ng, Arlene De Guzman, Ma Fe Natividad, Boots Daroy, Ma Luisa Cano, Jemellee Yu, Justine Lian, Michelle M. Zeng, Li Lim, Weng Khong Foo, Jia Nee Ng, Adeline S. L. Front Neurol Neurology Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis, particularly in cases with both FTD and amyotrophic lateral sclerosis (FTD-ALS). Mutations in three genes are associated with the majority of familial FTD (fFTD) cases - microtubule associated protein tau gene (MAPT), granulin precursor (GRN), and hexanucleotide repeat expansions in chromosome 9 open reading frame 72- SMCR8complex subunit (C9orf72) while mutations in other genes such as optineurin (OPTN) have rarely been reported. Mutations in OPTN have been reported mostly in familial and sporadic cases of ALS, or in rare cases of FTD-ALS, but not in association with pure or predominant FTD and/or parkinsonian phenotype. Here, we report for the first time, a family from the Philippines with four members harboring a novel frameshift insertion at OPTN (Chr 10:13166090 G>GA) p.Lys328GluTer11, three of whom presented with FTD-related phenotypes. Additionally, one sibling heterozygous for the frameshift insertion had a predominantly parkinsonian phenotype resembling corticobasal syndrome, but it remains to be determined if this phenotype is related to the frameshift insertion. Notably, none of the affected members showed any evidence of motor neuron disease or ALS at the time of writing, both clinically and on electrophysiological testing, expanding the phenotypic spectrum of OPTN mutations. Close follow-up of mutation carriers for the development of new clinical features and wider investigation of additional family members with further genetic analyses will be conducted to investigate the possibility of other genetic modifiers in this family which could explain phenotypic heterogeneity. Frontiers Media S.A. 2021-05-19 /pmc/articles/PMC8170397/ /pubmed/34093394 http://dx.doi.org/10.3389/fneur.2021.645913 Text en Copyright © 2021 Dominguez, Yu, Tan, Ng, De Guzman, Natividad, Daroy, Cano, Yu, Lian, Zeng, Lim, Foo and Ng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Dominguez, Jacqueline Yu, Jeryl Tan Tan, Yi Jayne Ng, Arlene De Guzman, Ma Fe Natividad, Boots Daroy, Ma Luisa Cano, Jemellee Yu, Justine Lian, Michelle M. Zeng, Li Lim, Weng Khong Foo, Jia Nee Ng, Adeline S. L. Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title | Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title_full | Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title_fullStr | Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title_full_unstemmed | Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title_short | Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis |
title_sort | novel optineurin frameshift insertion in a family with frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170397/ https://www.ncbi.nlm.nih.gov/pubmed/34093394 http://dx.doi.org/10.3389/fneur.2021.645913 |
work_keys_str_mv | AT dominguezjacqueline noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT yujeryltan noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT tanyijayne noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT ngarlene noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT deguzmanmafe noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT natividadboots noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT daroymaluisa noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT canojemellee noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT yujustine noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT lianmichellem noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT zengli noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT limwengkhong noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT foojianee noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis AT ngadelinesl noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis |